Mortality Trends from Urologic Cancers in Europe over the Period 1980–2017 and a Projection to 2025

European urology oncology - Tập 4 - Trang 677-696 - 2021
Paola Bertuccio1, Claudia Santucci2, Greta Carioli2, Matteo Malvezzi2, Carlo La Vecchia2, Eva Negri2,3
1Department of Biomedical and Clinical Sciences “L. Sacco”, Università degli Studi di Milano, Milan, Italy
2Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
3Department of Humanities, Pegaso Online University, Naples, Italy

Tài liệu tham khảo

Bosetti, 2011, Trends in mortality from urologic cancers in Europe, 1970–2008, Eur Urol, 60, 1, 10.1016/j.eururo.2011.03.047 Carioli, 2020, European cancer mortality predictions for the year 2020 with a focus on prostate cancer, Ann Oncol, 31, 650, 10.1016/j.annonc.2020.02.009 Cai, 2020, Estimates of over-time trends in incidence and mortality of testicular cancer from 1990 to 2030, Transl Androl Urol, 9, 182, 10.21037/tau.2020.02.22 Culp, 2020, Recent global patterns in prostate cancer incidence and mortality rates, Eur Urol, 77, 38, 10.1016/j.eururo.2019.08.005 Burger, 2013, Epidemiology and risk factors of urothelial bladder cancer, Eur Urol, 63, 234, 10.1016/j.eururo.2012.07.033 Cumberbatch, 2016, The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks, Eur Urol, 70, 458, 10.1016/j.eururo.2015.06.042 Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. In press. https://doi.org/10.1002/ijc.33588. World Health Organization, 1992 World Health Organization Statistical Information System. WHO mortality database. Geneva, Switzerland: World Health Organization; https://www.who.int/data/data-collection-tools/who-mortality-database. World Health Organization Statistical Information System. Health statistics and health information systems. WHO mortality database: tables. Estimated coverage of mortality data. https://wwwwhoint/healthinfo/statistics/morttables/en/. National Cancer Institute. Joinpoint regression program, version 4.1. Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z Clegg, 2009, Estimating average annual per cent change in trend analysis, Stat Med, 28, 3670, 10.1002/sim.3733 Carroll, 2018, NCCN guidelines updates: prostate cancer and prostate cancer early detection, J Natl Compr Canc Netw, 16, 620, 10.6004/jnccn.2018.0036 Litwin, 2017, The diagnosis and treatment of prostate cancer: a review, JAMA, 317, 2532, 10.1001/jama.2017.7248 Butler, 2020, Fatal prostate cancer incidence trends in the United States and England by race, stage, and treatment, Br J Cancer, 123, 487, 10.1038/s41416-020-0859-x Negoita, 2018, Annual report to the nation on the status of cancer, part II: recent changes in prostate cancer trends and disease characteristics, Cancer, 124, 2801, 10.1002/cncr.31549 Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 US Preventive Services Task Force, 2018, Screening for prostate cancer: US Preventive Services Task Force recommendation statement, JAMA, 319, 1901, 10.1001/jama.2018.3710 Jemal, 2021, Prostate cancer incidence 5 years after US Preventive Services Task Force recommendations against screening, J Natl Cancer Inst, 113, 64, 10.1093/jnci/djaa068 Scelo, 2021, Cancers emerging early in adulthood: analysis of trends and patterns in European cancer registries, Eur J Cancer, 143, 33, 10.1016/j.ejca.2020.10.026 Scott, 2020, Trends in cancer incidence in US adolescents and young adults, 1973–2015, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.27738 Gurney, 2019, International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries, Eur Urol, 76, 615, 10.1016/j.eururo.2019.07.002 Znaor, 2014, International variations and trends in testicular cancer incidence and mortality, Eur Urol, 65, 1095, 10.1016/j.eururo.2013.11.004 Znaor, 2012, Thirty year trends in testicular cancer mortality in Europe: gaps persist between the East and West, Acta Oncol, 51, 956, 10.3109/0284186X.2012.681701 Trama, 2015, Survival of male genital cancers (prostate, testis and penis) in Europe 1999–2007: results from the EUROCARE-5 study, Eur J Cancer, 51, 2206, 10.1016/j.ejca.2015.07.027 Znaor, 2020, Testicular cancer incidence predictions in Europe 2010–2035: a rising burden despite population ageing, Int J Cancer, 147, 820, 10.1002/ijc.32810 Santucci, 2020, Progress in cancer mortality, incidence, and survival: a global overview, Eur J Cancer Prev, 29, 367, 10.1097/CEJ.0000000000000594 Antoni, 2017, Bladder cancer incidence and mortality: a global overview and recent trends, Eur Urol, 71, 96, 10.1016/j.eururo.2016.06.010 Nadal, 2019, Management of metastatic bladder cancer, Cancer Treat Rev, 76, 10, 10.1016/j.ctrv.2019.04.002 Babjuk, 2013, EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013, Eur Urol, 64, 639, 10.1016/j.eururo.2013.06.003 Cumberbatch, 2018, Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018, Eur Urol, 74, 784, 10.1016/j.eururo.2018.09.001 Bafunno, 2019, Tobacco control in Europe: a review of campaign strategies for teenagers and adults, Crit Rev Oncol Hematol, 138, 139, 10.1016/j.critrevonc.2019.01.022 Huang J, Leung DK, Chan EO, et al. A global trend analysis of kidney cancer incidence and mortality and their associations with smoking, alcohol consumption, and metabolic syndrome. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.12.020. Perez-Farinos, 2006, Time trend and age-period-cohort effect on kidney cancer mortality in Europe, 1981–2000, BMC Public Health, 6, 119, 10.1186/1471-2458-6-119 Levi, 2008, The changing pattern of kidney cancer incidence and mortality in Europe, BJU Int, 101, 949, 10.1111/j.1464-410X.2008.07451.x Dy, 2017, Global burden of urologic cancers, 1990–2013, Eur Urol, 71, 437, 10.1016/j.eururo.2016.10.008 Molarius, 2001, Trends in cigarette smoking in 36 populations from the early 1980s to the mid-1990s: findings from the WHO MONICA project, Am J Public Health, 91, 206, 10.2105/AJPH.91.2.206 Weikert, 2008, Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition, Am J Epidemiol, 167, 438, 10.1093/aje/kwm321 Moore, 2010, Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants, Cancer Res, 70, 6527, 10.1158/0008-5472.CAN-09-4167 Dalmartello, 2020, Dietary patterns in Italy and the risk of renal cell carcinoma, Nutrients, 12, 134, 10.3390/nu12010134 Bai, 2020, The global, regional, and national burden of kidney cancer and attributable risk factor analysis from 1990 to 2017, Exp Hematol Oncol, 9, 27, 10.1186/s40164-020-00181-3 Boffetta, 2014, 57 Horn, 2020, Epidemiology of liver metastases, Cancer Epidemiol, 67, 10.1016/j.canep.2020.101760 Ryan C, Stoltzfus KC, Horn S, et al. Epidemiology of bone metastases. Bone. In press. https://doi.org/10.1016/j.bone.2020.115783:115783. Gosain, 2020, COVID-19 and cancer: a comprehensive review, Curr Oncol Rep, 22, 53, 10.1007/s11912-020-00934-7 Lai, 2020, Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study, BMJ Open, 10, 10.1136/bmjopen-2020-043828 Gheorghe, 2021, Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID -19 pandemic: a national population-based modelling study in England, UK, Eur J Cancer, 10.1016/j.ejca.2021.04.019 Kregting, 2021, Effects of cancer screening restart strategies after COVID-19 disruption, Br J Cancer, 124, 1516, 10.1038/s41416-021-01261-9